Eric D. Peselow

4.5k total citations
103 papers, 3.5k citations indexed

About

Eric D. Peselow is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Pharmacology. According to data from OpenAlex, Eric D. Peselow has authored 103 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Psychiatry and Mental health, 31 papers in Experimental and Cognitive Psychology and 29 papers in Pharmacology. Recurrent topics in Eric D. Peselow's work include Treatment of Major Depression (29 papers), Bipolar Disorder and Treatment (24 papers) and Schizophrenia research and treatment (22 papers). Eric D. Peselow is often cited by papers focused on Treatment of Major Depression (29 papers), Bipolar Disorder and Treatment (24 papers) and Schizophrenia research and treatment (22 papers). Eric D. Peselow collaborates with scholars based in United States, United Kingdom and Australia. Eric D. Peselow's co-authors include Stephen Ross, John Rotrosen, Michael Sanfilipo, Ronald R. Fieve, R R Fieve, Lenard A. Adler, Paul Block, Clive J. Robins, Burt Angrist and Burton Angrist and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Abnormal Psychology.

In The Last Decade

Eric D. Peselow

102 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric D. Peselow United States 38 1.5k 838 780 712 706 103 3.5k
Leon Grunhaus Israel 33 1.4k 1.0× 799 1.0× 907 1.2× 882 1.2× 1.1k 1.5× 130 4.4k
Jack G. Modell United States 31 1.2k 0.8× 786 0.9× 484 0.6× 913 1.3× 710 1.0× 52 3.6k
Otto Benkert Germany 33 1.8k 1.3× 737 0.9× 872 1.1× 1.1k 1.5× 508 0.7× 193 3.9k
George W. Arana United States 30 1.2k 0.8× 1.1k 1.4× 409 0.5× 484 0.7× 574 0.8× 76 3.7k
G Chouinard Canada 30 1.6k 1.1× 631 0.8× 601 0.8× 702 1.0× 330 0.5× 99 2.9k
H.‐J. Möller Germany 36 2.4k 1.7× 689 0.8× 384 0.5× 660 0.9× 767 1.1× 140 4.2k
L Annable Canada 33 1.6k 1.1× 655 0.8× 568 0.7× 420 0.6× 404 0.6× 93 3.0k
Eckart Rüther Germany 39 1.5k 1.0× 885 1.1× 1.1k 1.4× 320 0.4× 1.0k 1.5× 116 4.8k
Jürgen-Christian Krieg Germany 30 815 0.6× 815 1.0× 759 1.0× 364 0.5× 625 0.9× 71 3.0k
Armin Szegedi Germany 40 2.3k 1.6× 537 0.6× 784 1.0× 1.3k 1.8× 551 0.8× 120 4.6k

Countries citing papers authored by Eric D. Peselow

Since Specialization
Citations

This map shows the geographic impact of Eric D. Peselow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Peselow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Peselow more than expected).

Fields of papers citing papers by Eric D. Peselow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Peselow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Peselow. The network helps show where Eric D. Peselow may publish in the future.

Co-authorship network of co-authors of Eric D. Peselow

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Peselow. A scholar is included among the top collaborators of Eric D. Peselow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Peselow. Eric D. Peselow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peselow, Eric D., et al.. (2016). Polypharmacy in Maintenance of Bipolar Disorder. Clinical Neuropharmacology. 39(3). 132–134. 12 indexed citations
2.
IsHak, Waguih William, et al.. (2014). Patient-reported outcomes before and after treatment of major depressive disorder.. PubMed. 16(2). 171–83. 31 indexed citations
3.
Jaffe, Robert, et al.. (2013). Scopolamine as an Antidepressant. Clinical Neuropharmacology. 36(1). 24–26. 45 indexed citations
4.
Ross, Stephen & Eric D. Peselow. (2012). Co-Occurring Psychotic and Addictive Disorders. Clinical Neuropharmacology. 35(5). 235–243. 124 indexed citations
5.
Ross, Stephen & Eric D. Peselow. (2009). The Neurobiology of Addictive Disorders. Clinical Neuropharmacology. 32(5). 269–276. 94 indexed citations
6.
Case, Brady G., et al.. (2008). Discontinuation of Maintenance Selective Serotonin Reuptake Inhibitor Monotherapy After 5 Years of Stable Response. The Journal of Clinical Psychiatry. 69(11). 1811–1817. 9 indexed citations
7.
Zisook, Sidney, Ira D. Glick, James W. Jefferson, et al.. (2008). Teaching Psychopharmacology. Journal of Clinical Psychopharmacology. 28(1). 96–100. 11 indexed citations
8.
Malhi, Gin S., Melissa J. Green, Andrea Fagiolini, Eric D. Peselow, & Veena Kumari. (2008). Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disorders. 10(1p2). 215–230. 113 indexed citations
9.
Biel, Matthew G., et al.. (2007). Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study. Bipolar Disorders. 9(5). 435–442. 26 indexed citations
10.
Duncan, Erica, Sándor Miklós Szilágyi, Marion Schwartz, et al.. (2003). Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol. Psychiatry Research. 120(1). 1–12. 44 indexed citations
11.
Peselow, Eric D., et al.. (1996). Antecedent life events, social supports and response to antidepressants in depressed patients. Acta Psychiatrica Scandinavica. 94(5). 352–357. 16 indexed citations
12.
Peselow, Eric D., et al.. (1994). Personality Traits During Depression and After Clinical Recovery. The British Journal of Psychiatry. 164(3). 349–354. 54 indexed citations
13.
Peselow, Eric D., Clive J. Robins, Michael Sanfilipo, Paul Block, & et al. (1992). Sociotropy and autonomy: Relationship to antidepressant drug treatment response and endogenousonendogenous dichotomy.. Journal of Abnormal Psychology. 101(3). 479–486. 53 indexed citations
14.
Peselow, Eric D. & Ronald R. Fieve. (1992). Depressive Attributional Style and the Dexamethasone Suppression Test: Relationship to the Endogenous/Melancholic Distinction and to Each Other. Psychopathology. 25(4). 173–182. 3 indexed citations
15.
Peselow, Eric D., et al.. (1991). Relationship of dose to antidepressant prophylactic efficacy. Acta Psychiatrica Scandinavica. 84(6). 571–574. 8 indexed citations
16.
Welkowitz, Joan, Murray Alpert, Alizah Z. Brozgold, et al.. (1990). Parameters of emotional processing in neuropsychiatric disorders: Conceptual issues and a battery of tests. Journal of Communication Disorders. 23(4-5). 247–271. 146 indexed citations
17.
Block, Paul, et al.. (1989). Specificity of symptoms in RDC endogenous depression. Journal of Affective Disorders. 16(2-3). 243–248. 6 indexed citations
18.
Borod, Joan C., Murray Alpert, Alizah Z. Brozgold, et al.. (1989). A preliminary comparison of flat affect schizophrenics and brain-damaged patients on meausres of affective processing. Journal of Communication Disorders. 22(2). 93–104. 56 indexed citations
19.
Deutsch, Stephen I., Michael Stanley, Eric D. Peselow, & Miriam Banay‐Schwartz. (1983). Glycine: A Possible Role in Lithium’s Action and Affective Illness. Neuropsychobiology. 9(4). 215–218. 6 indexed citations
20.
Peselow, Eric D., David L. Dünner, Ronald R. Fieve, Stephen I. Deutsch, & Morton Rubinstein. (1982). Age of Onset of Affective Illness. Psychopathology. 15(3). 124–132. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026